Project Details
Description / Abstract
To appraise the clinical and cost effectiveness of eluxadoline within its marketing authorisation for treating irritable bowel syndrome
with diarrhoea.
with diarrhoea.
| Status | Finished |
|---|---|
| Effective start/end date | 19/10/16 → 25/01/17 |
| Links | http://fundingawards.nihr.ac.uk/award/15/121/13 |